Electrocompetent Cells Market,By Application (Cloning, Protein Expression, Mutagenesis, Genomic DNA Library Construction, Antibody Production, High-Throughput Screening, Others), By Cell Type (Escherichia coli (E. coli), Saccharomyces cerevisiae (S. cerevisiae), Bacillus subtilis (B. subtilis), Pseudomonas putida (P. putida), Streptococcus pneumoniae (S. pneumoniae), Others), By Transformation Efficiency (High Efficiency Cells, Ultra-High Efficiency Cells), By Packaging Format (Tubes, Plates, Custom Formats), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs), Others), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Electrocompetent cells are bacterial strains that are capable of receiving and transferring foreign DNA by the process of electrotransformation. They are typically prepared by a time-consuming and labor-intensive method that involves extensive washing and centrifugation, as well as maintaining the cells at an ice-cold temperature. The traditional procedure also results in a low transformation efficiency, making it difficult to generate high quality clones using this technique.
Market Dynamics:
There is a rise in research activities and funding activities in molecular cloning studies. This in turn is expected to boost the demand for competent cells as they are highly efficacious in various biotechnology procedures. This factor is expected to support growth of the global electrocompetent cells market over the forecast period.
However, the need for skilled professionals having sound technical knowledge is one of the major factors expected to hamper growth of the global electrocompetent cells market over the forecast period.
Key features of the study:
This report provides in-depth analysis of the global electrocompetent cells market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global electrocompetent cells market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., QIAGEN N.V., Bio-Rad Laboratories, Inc., New England Biolabs, Inc., GenScript Biotech Corporation, Lucigen Corporation, Takara Bio Inc., Delphi Genetics S.A., IBA GmbH, Scarab Genomics LLC, Zymo Research Corporation, Bioline GmbH (Meridian Bioscience), and Cell Applications, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global electrocompetent cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global electrocompetent cells market
Detailed Segmentation:
Global Electrocompetent Cells Market, By Application:
Cloning
Protein Expression
Mutagenesis
Genomic DNA Library Construction
Antibody Production
High-Throughput Screening
Others
Global Electrocompetent Cells Market, By Cell Type
Escherichia coli (E. coli)
Saccharomyces cerevisiae (S. cerevisiae)
Bacillus subtilis (B. subtilis)
Pseudomonas putida (P. putida)
Streptococcus pneumoniae (S. pneumoniae)
Others
Global Electrocompetent Cells Market, By Transformation Efficiency:
High Efficiency Cells
Ultra-High Efficiency Cells
Global Electrocompetent Cells Market, By Packaging Format:
Tubes
Plates
Custom Formats
Global Electrocompetent Cells Market, By End User:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Contract Research Organizations (CROs)
Others
Global Electrocompetent Cells Market, By Region:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Company Profiles:
Thermo Fisher Scientific Inc.
Merck KGaA
Agilent Technologies, Inc.
QIAGEN N.V.
Bio-Rad Laboratories, Inc.
New England Biolabs, Inc.
GenScript Biotech Corporation
Lucigen Corporation
Takara Bio Inc.
Delphi Genetics S.A.
IBA GmbH
Scarab Genomics LLC
Zymo Research Corporation
Bioline GmbH (Meridian Bioscience)
Cell Applications, Inc.